 |
 |
On 16 May 99 at 10:57, Phil Tompkins wrote: > Today's (Sunday May 16) New York Times contains part 1 of 2 of a long > expose article (two full pages) on fees paid by drug companies to > physicians to conduct clinical trials or to refer patients to > clinical trials, and cites abuses which this practice has led to or > could lead to. SNIP I can sure see the conflicts all right. Thanks Phil. Now here is a site that outlines the processes to bring a drug to market. http://www.phrma.org/charts/approval.html All the best ........ Murray [log in to unmask]